Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 8;24(19):3626.
doi: 10.3390/molecules24193626.

Red Wine Consumption and Cardiovascular Health

Affiliations
Review

Red Wine Consumption and Cardiovascular Health

Luigi Castaldo et al. Molecules. .

Abstract

Wine is a popular alcoholic beverage that has been consumed for hundreds of years. Benefits from moderate alcohol consumption have been widely supported by the scientific literature and, in this line, red wine intake has been related to a lesser risk for coronary heart disease (CHD). Experimental studies and meta-analyses have mainly attributed this outcome to the presence in red wine of a great variety of polyphenolic compounds such as resveratrol, catechin, epicatechin, quercetin, and anthocyanin. Resveratrol is considered the most effective wine compound with respect to the prevention of CHD because of its antioxidant properties. The mechanisms responsible for its putative cardioprotective effects would include changes in lipid profiles, reduction of insulin resistance, and decrease in oxidative stress  of low-density lipoprotein cholesterol (LDL-C). The aim of this review is to summarize the accumulated evidence correlating moderate red wine consumption with prevention of CHD by focusing on the different mechanisms underlying this relationship. Furthermore, the chemistry of wine as well as chemical factors that influence the composition of the bioactive components of red wine are also discussed.

Keywords: alcohol; antioxidants; cardioprotective; polyphenols; red wine; resveratrol.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest

References

    1. Yu C., Moore B.M., Kotchetkova I., Cordina R.L., Celermajer D.S. Causes of death in a contemporary adult congenital heart disease cohort. Heart. 2018;104:1678–1682. doi: 10.1136/heartjnl-2017-312777. - DOI - PubMed
    1. Chiva-Blanch G., Arranz S., Lamuela-Raventos R.M., Estruch R. Effects of Wine, Alcohol and Polyphenols on Cardiovascular Disease Risk Factors: Evidences from Human Studies. Alcohol Alcohol. 2013;48:270–277. doi: 10.1093/alcalc/agt007. - DOI - PubMed
    1. Steven S., Frenis K., Oelze M., Kalinovic S., Kuntic M., Jimenez M.T.B., Vujacic-Mirski K., Helmstädter J., Kröller-Schön S., Münzel T., et al. Vascular Inflammation and Oxidative Stress: Major Triggers for Cardiovascular Disease. Oxidative Med. Cell. Longev. 2019;2019:1–26. doi: 10.1155/2019/7092151. - DOI - PMC - PubMed
    1. Bozkurt B., Aguilar D., Deswal A., Dunbar S.B., Francis G.S., Horwich T., Jessup M., Kosiborod M., Pritchett A.M., Ramasubbu K., et al. Contributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association. Circulation. 2016;134:535. doi: 10.1161/CIR.0000000000000450. - DOI - PubMed
    1. Roerecke M., Rehm J. Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med. 2014;12:182. doi: 10.1186/s12916-014-0182-6. - DOI - PMC - PubMed